RecruitingNCT06853665

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

This study is recruiting. It focuses on ADHD and currently lists participation information in the United States.

ADHDOtherFrom 8 Years to 18 Years

Need help deciding?

Ask HopeStage to review this study with me

Leave your email and HopeStage can help you better understand this study.

Study reference: NCT06853665. HopeStage can help you review the study, but cannot decide medical eligibility.

In plain English

Key information made simple

This study is looking at help researchers better understand how the use of MAS to treat ADHD effects children and adolescents with ASD for people with Attention Deficit Hyperactivity Disorder, Autism, or Autism Spectrum Disorder. Participants receive Adderall XR (mixed salts amphetamine) or placebo and complete study visits and assessments. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a hospital, with sites including Massachusetts General Hospital in Boston. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Before joining

Questions to ask before joining

What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?

Study clarity

Things to check before joining

Sponsor: Gagan Joshi
Sponsor type: Unknown or unclear
Main activity: medication or study treatment
Intervention: Not available
Time commitment: multiple visits or assessments
Study phase: Not available
Enrollment: Not available
Recruitment status: Recruiting
Source: Official registry link

Public study data

Key study information

Official title: The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
Condition: Attention Deficit Hyperactivity Disorder (ADHD); Autism; Autism Spectrum Disorder
Study status: Recruiting
Sponsor / lead affiliation: Gagan Joshi
Location / country: United States
Registry: ClinicalTrials.gov
External trial ID: NCT06853665

Why this study may matter

This study may matter because it adds public evidence around adhd. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular visits and structured follow-up.

Mixes in-person and remote participation.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Official title: The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
Source: ClinicalTrials.gov
Official registry link: Open official registry
External trial ID: NCT06853665

Open source record

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with placebo. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by Gagan Joshi. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me